TNF and rheumatoid arthritis: Many biological therapies are now available for patients with rheumatoid arthritis (RA) who have an inadequate response to synthetic disease modifying antirheumatic drugs (sDMARD) especially methotrexate (MTX) or to a first tumor necrosis factor (TNF) inhibitor (TNFi).